Altogether, these data highlight SDC2 as a highly valuable biomarker, and the simple and affordable single-target sDNA test based on methylated SDC2 is capable of detecting early CRC with substantial accuracy. The gene discussed is SDC2; the disease is colorectal carcinoma.